We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Mouse Model Study Supports Sexual Transmission of Zikavirus Infection

By LabMedica International staff writers
Posted on 26 Apr 2016
A newly established mouse model, which is expected to accelerate efforts to develop a vaccine to protect against Zikavirus (ZIKV) infection, revealed high levels of the virus in the testes of the animals, a finding that supports the possible sexual transmission of the disease.

Investigators at Washington University School of Medicine (St. More...
Louis, MO, USA) used wild-type (WT) C57BL/6 mice, as well as a large panel of immune-deficient transgenic mice together with several different strains of ZIKV including a contemporary clinical isolate. In this study, the mice were infected via the skin in a manner that mimicked the bite of the mosquito vector of the disease.

The investigators reported in the April 5, 2016, online edition of the journal Cell Host & Microbe that whereas four- to six-week-old WT mice did not develop clinically apparent disease, mice lacking interferon alpha/beta (IFN-alpha/beta) signaling (genetically engineered triple knockout [TKO] mice) succumbed to infection with all the different ZIKV strains. Viral burden analysis revealed that mice lacking the interferon receptor (Ifnar1−/− mutants), but not WT mice, sustained high levels of ZIKV in all tissues tested, including serum, spleen, brain, spinal cord, and testes. The testes of Ifnar1−/− mice had the highest viral loads, which is relevant to the possible sexual transmission of ZIKV.

"Now that we know the mice can be vulnerable to Zika infection, we can use the animals to test vaccines and therapeutics - and some of those studies are already underway - as well as to understand the pathogenesis of the virus," said senior author Dr. Michael Diamond, professor of medicine at Washington University School of Medicine.

"We looked for evidence of Zika in the mouse testes mostly as an afterthought, due to mounting evidence of sexual transmission and were surprised that viral levels were the highest we saw in any tissue," said Dr. Diamond. "We are now doing subsequent tests to determine how long those viral levels are sustained, which could help us estimate the length of time Zika can be transmitted sexually."

Related Links:
Washington University School of Medicine

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.